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Abstract
Purpose To evaluate the effect of mitochondrial transfer on
embryonic development.
Materials and methods Mitochondria concentrates were
collected from murine hepatocytes and fertilized murine
zygotes from young and older mice in the 2PN stage were
subjected to mitochondrial transfer and cultured in vitro to
evaluate the embryonic development.
Results After extended in vitro culture, 37.65% and 20.91%
embryos from the young mice developed to the blastocyst
stage in the injected and control groups respectively, which
is statistically significant. There was no difference in terms
of hatching rates (1.76% and 1.82% respectively). Zygotes
from the older mice (>20 weeks old) that received
mitochondrial transfer also had a better developmental
outcome than the control group (54.35% and 18.92%
developed to morula stage, 43.48% and 8.11% developed
to the blastocyst stage respectively), which is statistically
significant.
Conclusions Our results for the murine model provide
direct scientific evidence that mitochondrial transfer
improves embryonic development. However, potential risks
such as mitochondrial heteroplasmy, nuclear-mitochondrial
interaction and epigenetic aspects all deserve further
evaluation before mitochondrial transfer is applied clinically.
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Introduction
With advances of assisted reproduction techniques, suc-
cessful pregnancy rates have increased to nearly 40–50% in
some centers, however, there are still some patients who
suffer repeatedly from failed trials, especially those with
poor ovarian reserves and poor embryonic development.
There have been various attempts to improve results,
including alteration of stimulation regimens, ICSI, co-
culture, alternative culture methods, assisted hatching and
fragment removal etc. But the results are still disappointing.
It has been suggested that the introduction of a small
amount of ooplasm from a healthy donor oocyte might
rescue the function of oocytes that may have certain
ooplasm deficiencies [1]. Ooplasm transfer has been
attempted in humans and a few pregnancies have resulted
[2–4]. However, it is not yet fully clear how ooplasm
transfer works. In recent years, adenosine triphosphate
(ATP)-producing capacity of germ line cells has been
correlated with reproductive performance [5]. Perez et al.
[6] microinjected a small number of mitochondria into
mouse oocytes and found that the procedure prevented
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oocytes from undergoing apoptosis. Their data provides a
direct correlation between ATP-producing capacity and
reproductive performance and helped, at least partly, in
elucidating the ooplasmic factors. In the same report, they
also showed the occurrence of a common mitochondrial
DNA (mtDNA) deletion in unfertilized human oocytes are
more frequent as compared with fertilized oocytes, this
indicates the status of mtDNA integrity is associated with
potential fertility of oocytes. Later, the concept of mito-
chondrial transfer was proposed and practiced in women
who suffered from repeated pregnancy failure and resulted
in clinical pregnancies [7]. However, there is still no proper
pre-clinical evaluation about the efficiency of mitochondrial
transfer on embryonic development; this also limits its
application. To further evaluate the effects of mitochondrial
transfer on embryonic development, we injected the
mitochondria extracted from mice hepatocytes into zygotes
from young or older mice to compare the developmental
outcome of zygotes with or without mitochondrial transfer.
Materials and methods
Preparation of fertilized mouse oocytes
Four- to 6-week-old young female ICR mice and “older
mice ” consisted of female ICR mice older than 20 weeks
received intraperitoneal injection of 10 IU PMSG (Sigma,
St. Louis, MO, US) followed by intraperitoneal injection of
10 IU HCG (Serono) 48 h later. They were mated with male
mice and successful mating was checked by vaginal plug.
The mated female mice were sacrificed by CO2 inhalation
followed by cervical dislocation. The oviducts were
dissected in 10 mmol HEPES buffered Human Tubal Fluid
(HTF) and apparently healthy fertilized oocytes in the 2PN
stage were collected and cultured in HTF supplemented
with 0.5% human serum albumin (HSA, Sigma).
Preparation of mitochondria
The mitochondria were prepared by a modified method
described by Pinkert et al. [8]. Briefly, the mice liver tissues
measured as 2×2×1 mm were minced in a solution of
5 mM MOPS (pH7.4), 250 mM sucrose and 0.5 mM
EDTA. (maintained at 4°C), minced tissues were rinsed
twice, homogenized with a glass/Teflon homogenizer at 106
cells per ml buffer. The crude homogenate was centrifuged
twice for 15 min at 800 g and the pellets were discarded.
The supernatant was again centrifuged for 20 min at
9,800 g. The pellet was re-suspended very slowly by
drop-wise dilution with 200 μl of IVF30 medium (Vitrolife,
Kungsbacka, Sweden). It was then maintained at 4°C until
used for microinjection.
Preparation of micropipettes and micromanipulation
The micropipettes were made from thin-walled borosilicate
glass tubes with an outer diameter of 1.0 mm and an inner
diameter of 0.75 mm (Drummond Scientific Company,
Broomall, PA, US). The holding pipette was made with an
outer diameter of 60 (60–80) μm and polished to an inner
diameter of 20 (20–30) μm. The transfer pipette was made
with an outer diameter of 5 μm and inner diameter of 3 μm
for the mouse embryo. The pipettes were bent at an angle of
20–25 degree to allow horizontal movement. The pipettes
were sterilized using dry heat at 160°C for 2 h.
Five droplets of 5 μl 10 mmol HEPES-buffered HTF
medium (for mouse oocytes) were placed on one line in the
middle of the cover of a Falcon dish 3002. One droplet of
mitochondrial suspension was placed in the right side of
HEPES-buffered droplets. The droplets were covered with
paraffin oil.
Mitochondrial transfer procedure
The holding and transfer pipettes were mounted on the
microscope (Nikon Diaphot 200) of the micromanipulator
system (RI TDU500 Micromanipulator, Falmouth, Corn-
wall, UK) in a similar way as for ICSI.
Up to five zygotes at the 2PN stage were placed in the
dish, one in each HEPES droplet. The dish was placed on
the heated stage of the microscope and the droplet of the
mitochondrial suspension was visualized. The transfer
pipette was lowered into the droplet of mitochondrial
suspension and the mitochondrial suspension was aspirated
for about 1800–2000 μm. The aspiration was stopped and
the dish was moved to visualize the first zygote. The
holding pipette was lowered into the droplet and the
zygotes were fixed on the holding pipette. The zygotes
were immobilized by slight negative pressure. The polar
body was held at 6 o’clock. The transfer pipette was then
lowered. The transfer pipette was pushed through the zona
pellucida and the oolemma into the ooplasma at 3 o’clock.
The mitochondrial suspension about 4 pl was injected into
the ooplasma. The transfer pipette was withdrawn gently
and the injected zygotes were released from the holding
pipette. The number of mitochondria transferred per zygote
was estimated about 4000. The transfer procedure was
repeated for all the zygotes in the dish.
Evaluation of subsequent fertilization and embryo
development
The manipulated zygotes were cultured individually in a
micro-droplet environment for 5 more days. They were
observed each day for further division, formation of
morula, blastocyst and hatching. The developmental rates
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in each experimental and control group were calculated and
statistically compared.
Statistics
Statistical analysis was performed with the Statistical
Package for Social Sciences (SPSS v 12.0 for Windows,
Chicago, IL). Statistical significance was assessed using the
t test. At P<.05, the difference was considered to be
statistically significant.
Results
For experiments with the young mice, we performed
mitochondrial transfer in 13 replicates, a total of 170
zygotes were successfully injected, and another 110 zygotes
were cultured at the same time as the control. During
extended in vitro culture for another five days, 37.65% and
20.91% embryos developed to blastocysts in the injected
and control groups respectively, which is statistically
significant. There was no difference in terms of hatching
rates. (1.76% and 1.82% respectively) (Table 1)
We also performed mitochondrial transfer in older mice
(>20 weeks old) in another four replicates, there were better
developmental outcomes in the injected than control group
(54.35% and 18.92% developed to morula stage respec-
tively, 43.48% and 8.11% developed to the blastocyst stage
respectively), which is statistically significant (Table 2).
Discussion
With the use of assisted fertilization techniques, a success-
ful pregnancy rate per treatment cycle of approximately
40% can be expected in most centers. However, repeated
failures still occur in some patients even after many
treatment cycles. In 1997, Cohen et al. [9] reported the
first successful pregnancy following the transfer of cyto-
plasm from donor oocytes into the oocytes of a patient with
a history of poor embryo development and recurrent
implantation failure, yet the live birth of five healthy
children was reported by the end of 1998 [2]. However,
there are still some concerns about the risk of cytoplasmic
transfer [10], including the transmission of infectious agents
or other unfavorable apoptotic factors [11], the sources of
donated cytoplasm also causes problems. To further
delineate the possible mechanism of cytoplasm transfer on
recipient oocytes and seek solutions, there have been many
studies and different hypothesis about the beneficial effects
of cytoplasm transfer on embryo development [12]: one is
the correction of imbalances between anti-apoptotic and
pro-apoptotic factors, another is correction of a defective
mitochondrial membrane potential. Healthy mitochondria
are essential for accurate chromatid segregation at the time
of mitotic division; they are also responsible for respiratory
processes and ATP production. The idea of mitochondrial
transfer to increase ATP production was proposed in 1998
[13], and microinjection studies using purified mitochon-
dria from granulosa cells showed suppression of apoptosis
in cultured mouse oocyte by 50% [6] indicating the “rescue
effect” of mitochondria in a compromised mouse oocyte
developed in vitro. Mitochondria transfer into oocyte from
autologous cumulus granulosa cells (cGCs) was practiced
in infertile women with repeatedly failed IVF trials and
resulted in a clinical pregnancy by 2001 [7]. This
encouraging result revealed that mitochondria might play
an important role in embryo development and implantation.
Recently, studies showed the average mitochondrial
DNA (mtDNA) copy number was significantly lower in
oocytes suffering from fertilization failures compared to
cohorts with a normal rate of fertilization [14], and
developmentally arrested embryos may contain mtDNA
contents that are large enough to achieve a good grading
but may not be able to support further development and
implantation [15]. These findings about mtDNA amount
and embryo development [16, 17] support the theoretical
Table 1 Development outcomes of injected and non-injected young
mice zygotes
Morula
formation rate
(%)
Blastocyst
formation rate
(%)*
Hatching
rate (%)
Mitochondrial
injected (170)a
38.8% (66) 37.65% (64) 1.76% (3)
Non-injected
control (110)
27.27% (30) 20.91% (23) 1.82% (2)
P value 0.06 0.04 0.72
aEmbryo numbers are in the parenthesis. Values are presented as the
mean ± SD.
*P<0.05
Table 2 Development outcomes of injected and non-injected mice
zygotes in elder mice
Morula
formation rate
(%)*
Blastocyst
formation rate
(%)*
Hatching
rate (%)
Mitochondrial
injected (46)a
54.35% (25) 43.48% (20) 0% (0)
Non-injected
controls (37)
18.92% (7) 8.11% (3) 0% (0)
P value 0.045 0.01 N.S.
a Embryo numbers are in the parenthesis. Values are presented as the
mean ± SD.
*P<0.05
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benefits of mitochondrial transfer on pregnancy outcomes.
While clinical trials of mitochondrial transfer in women
with recurrent pregnancy failures showed good results,
there is still no case-control or randomized study about the
real effects of mitochondrial transfer on embryonic devel-
opment, so the beneficial effects of mitochondrial transfer
are only “hypothetic”. This also limits its further applica-
tion. In these studies, we performed autologous mitochon-
drial transfer in mice zygotes, and the results showed more
recipient zygotes developed to the blastocyst stage than
those without mitochondrial transfer in both young and
older mice. These results provide direct scientific evidence
that mitochondrial transfer is efficient in improving embry-
onic development.
In humans, germ-line cells are derived from primordial
germ cells, which are conspicuous in the developing
embryo by the third week after conception. Quiescent
primordial follicles might not enter meiotic division for
decades, and therefore they are expected to accumulate
abundant mutant mtDNA in oocytes [18, 19], accumulation
of mtDNA deletions may contribute to mitochondrial
dysfunction and impaired ATP production and thus im-
paired oocyte fertilization and further embryonic growth
[20]. Studies of mitochondrial DNA (mtDNA) mutations
have also revealed that the accumulation of mtDNA
rearrangements or deletions may contribute to mitochon-
drial dysfunction and interfere with fertilization of human
oocytes and further embryonic development [21]. Taken
together, insufficient amounts of mitochondria, altered
mitochondrial function by accumulated mutation, inade-
quate redistribution of mitochondria, unsuccessful mito-
chondrial differentiation, or decreased mitochondrial
transcription [22] may result in poor oocyte fertilization
and compromised embryo development [23]. In the other
words, successful fertilization and embryo development
need adequate functional mitochondria in terms of both
quantity and quality. The mitochondrial transfer provides
extra amounts of mitochondria with relative good quality,
which not only correct the quantity deficit, but may also
correct the quality deficit by diluting the pre-existing
mutated mtDNA accumulated in compromised oocytes
and may improve the embryonic developmental potential.
Interestingly, in our study, the mitochondrial transfer can
improve morula formation rate in zygotes from older but
not young mice. Though we cannot jump to a definite
conclusion that mitochondria transfer are more effective for
embryo development in older mice than young mice from
this limited data in the meanwhile, previous studies have
shown that the mitochondrial gene transcription levels are
significantly decreased in unfertilized oocytes and arrested
embryos compared with 3PN embryos [22], and embryos
may fail to achieve further development due to insufficient
mitochondrial amounts [15]. Thus, it is reasonable to
postulate that there may be “thresholds’ present that gate
each step of embryonic development, and the zygotes from
young mice may contain sufficient intrinsic mitochondrial
pools to support morula development; the zygotes from
older mice may not contain enough functional mitochondria
to support morula development, partly due to accumulated
mtDNA rearrangement, hence the mitochondrial transfer
can improve morula formation rates in elder but not young
mice. The failure to improve hatching rate, suggests the
mitochondria pool, even after mitochondrial transfer, still
cannot overcome the “threshold”. To further delineate the
efficiency of mitochondria transfer, we plan to perform
further experiments to study the effects of mitochondria
transfer in mice zygotes cohorts with different degree of
mitochondrial DNA rearrangements.
In conclusion, the current study provides evidence that
mitochondrial transfer can improve embryonic develop-
ment. However, the adequate mitochondria amounts re-
quired for transfer, and risks such as mitochondrial
heteroplasmy [7, 24], nuclear-mitochondrial interaction
and epigenetic aspects all deserve further evaluation before
mitochondrial transfer can be applied clinically.
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